Web Results

melinta.com

Press Releases · Events & Presentations · Corporate Governance · Financial Information · Stock Information · Investor FAQs · Contact Us · Join Our Team · Contact. to cure serious infections. MELINTA THERAPEUTICS, INC. - THE ANTIBIOTICS COMPANY ©2018 ALL RIGHTS RESERVED | Privacy Policy | Terms of Use.

seekingalpha.com/article/4097310-cempra-melintas-lesson-value-destruction

Aug 10, 2017 ... "If you want to be a millionaire start with a billion dollars and launch a new airline, " the entrepreneur Richard Branson once said. The aphorism can often be applied to biotech too, and one demonstration of this type of value destruction came yesterday courtesy of a merger between Cempra ...

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=28675941

As of November 3, 2017, Cempra, Inc. was acquired by Melinta Therapeutics, Inc. , in a reverse merger transaction. Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing anti-infectives for the acute care and community settings to meet critical medical needs in the treatment of infectious diseases in ...

finance.yahoo.com/q?s=cemp

SymbolCompany NameLast PriceIndustry / CategoryTypeExchange. CEMP Cempra, Inc.2.33BiotechnologyStocksNMS. CSFVictoryShares US Discv Enh Vol Wtd ETF45.41N/AETFNGM. CEZVictoryShares Emerging Mkt Vol Wtd ETF30.44 N/AETFNGM. CDCLehman ABS Corp.46.56N/AETFNGM. CFOVictoryShares US 500 ...

finance.yahoo.com/quote/CEMP

View the basic CEMP stock chart on Yahoo Finance. Change the date range, chart type and compare Cempra Inc against other companies.

globenewswire.com/news-release/2017/08/09/1082518/0/en/Cempra-and-Melinta-Announce-Merger-to-Form-Leading-Vertically-Integrated-Commercial-Stage-Anti-Infectives-Company.html

Aug 9, 2017 ... CHAPEL HILL, N.C. and NEW HAVEN, Conn., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and community settings to meet critical medical needs in the treatment of ...

globenewswire.com/news-release/2017/11/03/1174628/0/en/Cempra-Announces-Preliminary-Results-of-2017-Stockholder-Vote.html

Nov 3, 2017 ... CHAPEL HILL, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. ( Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and community settings to meet critical medical needs in the treatment of infectious diseases, today ...

www.fool.com/investing/2016/12/29/why-cempra-got-slaughtered-today.aspx

Dec 29, 2016 ... Why Cempra Inc. Got Hammered Down Today. Brian Orelli | Dec 20, 2016. The biotech receives an analyst downgrade ahead of an FDA decision. Head in sand  ...

www.marketwatch.com/investing/stock/cemp

Cempra Inc. stock price, stock quotes and financial overviews from MarketWatch.